Lanean...

An RNA Aptamer Targeting the Receptor Tyrosine Kinase PDGFRα Induces Anti-tumor Effects through STAT3 and p53 in Glioblastoma

Human glioblastoma (GBM) is the most aggressive malignancy of the CNS, with less than 5% survival. Despite great efforts to find effective therapeutics, current options remain very limited. To develop a targeted cancer therapeutic, we selected RNA aptamers against platelet-derived growth factor rece...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Sorah Yoon, Xiwei Wu, Brian Armstrong, Nagy Habib, John J. Rossi
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Elsevier 2019-03-01
Saila:Molecular Therapy: Nucleic Acids
Sarrera elektronikoa:http://www.sciencedirect.com/science/article/pii/S2162253118303068
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!